- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q1 (20) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.47 | 0.0 | 0.0 | 9.60 | 0.0 | 0.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q4 (19) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.47 | 0.0 | 0.0 | 9.60 | 0.0 | 0.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q3 (18) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.47 | 0.0 | 0.0 | 9.60 | 0.0 | 0.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q2 (17) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.47 | 0.0 | 0.0 | 9.60 | 0.0 | 0.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q1 (16) | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 23.47 | 0.0 | 0.0 | 9.60 | 0.0 | 0.0 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
| 22Q4 (15) | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 23.47 | 0.0 | 15.04 | 9.60 | 0.0 | 13.91 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
| 22Q3 (14) | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | -100.0 | 0 | 0 | 0 | 23.47 | 0.0 | -0.07 | 9.60 | 0.0 | -8.28 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
| 22Q2 (13) | 0 | -100.0 | -100.0 | 0 | -100.0 | -100.0 | 0 | -100.0 | -100.0 | 0 | 0 | 0 | 23.47 | 0.0 | 18.35 | 9.60 | 0.0 | 25.22 | 0.00 | 0 | 0 | 0 | -100.0 | -100.0 |
| 22Q1 (12) | 17.81 | -14.7 | -24.31 | 4.18 | -1.88 | -9.52 | 1.71 | -2.84 | -9.52 | 0 | 0 | 0 | 23.47 | 15.04 | 19.53 | 9.60 | 13.91 | 19.53 | 0.00 | 0 | 0 | 661 | 0.0 | -8.45 |
| 21Q4 (11) | 20.88 | 10.95 | -20.61 | 4.26 | -3.62 | -11.8 | 1.76 | -10.66 | -15.38 | 0 | 0 | 0 | 20.40 | -13.13 | 11.09 | 8.43 | -19.47 | 6.58 | 0.00 | 0 | 0 | 661 | 0.0 | -8.45 |
| 21Q3 (10) | 18.82 | -24.45 | -34.4 | 4.42 | -10.53 | -15.49 | 1.97 | 3.14 | -20.24 | 0 | 0 | 0 | 23.49 | 18.43 | 28.83 | 10.47 | 36.52 | 21.59 | 0.00 | 0 | 0 | 661 | 0.0 | -8.45 |
| 21Q2 (9) | 24.91 | 5.86 | 2.01 | 4.94 | 6.93 | 15.96 | 1.91 | 1.06 | -6.37 | 0 | 0 | 0 | 19.83 | 1.0 | 13.68 | 7.67 | -4.54 | -8.21 | 0.00 | 0 | 0 | 661 | -8.45 | -8.45 |
| 21Q1 (8) | 23.53 | -10.53 | -0.84 | 4.62 | -4.35 | -7.78 | 1.89 | -9.13 | -10.0 | 0 | 0 | 0 | 19.63 | 6.91 | -7.0 | 8.03 | 1.56 | -9.24 | 0.00 | 0 | 0 | 722 | 0.0 | -8.38 |
| 20Q4 (7) | 26.3 | -8.33 | -8.2 | 4.83 | -7.65 | -13.75 | 2.08 | -15.79 | -12.24 | 0 | 0 | 0 | 18.37 | 0.74 | -6.04 | 7.91 | -8.14 | -4.39 | 0.00 | 0 | 0 | 722 | 0.0 | -8.38 |
| 20Q3 (6) | 28.69 | 17.49 | -2.12 | 5.23 | 22.77 | -9.36 | 2.47 | 21.08 | -14.83 | 0 | 0 | 0 | 18.23 | 4.5 | -7.4 | 8.61 | 3.06 | -12.99 | 0.00 | 0 | 0 | 722 | 0.0 | -8.38 |
| 20Q2 (5) | 24.42 | 2.91 | -18.0 | 4.26 | -14.97 | -28.04 | 2.04 | -2.86 | -23.02 | 0 | 0 | 0 | 17.44 | -17.37 | -12.25 | 8.35 | -5.6 | -6.12 | 0.00 | 0 | 0 | 722 | -8.38 | -8.38 |
| 20Q1 (4) | 23.73 | -17.17 | 0.0 | 5.01 | -10.54 | 0.0 | 2.1 | -11.39 | 0.0 | 0 | 0 | 0.0 | 21.11 | 8.01 | 0.0 | 8.85 | 6.98 | 0.0 | 0.00 | 0 | 0.0 | 788 | 0.0 | 0.0 |
| 19Q4 (3) | 28.65 | -2.25 | 0.0 | 5.6 | -2.95 | 0.0 | 2.37 | -18.28 | 0.0 | 0 | 0 | 0.0 | 19.55 | -0.71 | 0.0 | 8.27 | -16.39 | 0.0 | 0.00 | 0 | 0.0 | 788 | 0.0 | 0.0 |
| 19Q3 (2) | 29.31 | -1.58 | 0.0 | 5.77 | -2.53 | 0.0 | 2.9 | 9.43 | 0.0 | 0 | 0 | 0.0 | 19.69 | -0.97 | 0.0 | 9.89 | 11.19 | 0.0 | 0.00 | 0 | 0.0 | 788 | 0.0 | 0.0 |
| 19Q2 (1) | 29.78 | 0.0 | 0.0 | 5.92 | 0.0 | 0.0 | 2.65 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 19.88 | 0.0 | 0.0 | 8.90 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 788 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 (10) | 88.15 | -14.54 | 18.24 | -5.64 | 7.53 | -13.45 | 0 | 0 | 20.69 | 10.42 | 8.54 | 1.28 | 0.00 | 0 | 661 | -8.45 |
| 2020 (9) | 103.15 | -12.12 | 19.33 | -16.79 | 8.7 | -16.18 | 0 | 0 | 18.74 | -5.32 | 8.43 | -4.63 | 0.00 | 0 | 722 | -8.38 |
| 2019 (8) | 117.37 | -2.3 | 23.23 | 1.35 | 10.38 | 1.57 | 0 | 0 | 19.79 | 3.74 | 8.84 | 3.95 | 0.00 | 0 | 788 | 0.0 |
| 2018 (7) | 120.13 | 0.84 | 22.92 | 2.05 | 10.22 | -0.39 | 0 | 0 | 19.08 | 1.2 | 8.51 | -1.22 | 0.00 | 0 | 788 | -5.29 |
| 2017 (6) | 119.13 | -2.36 | 22.46 | 2.04 | 10.26 | -0.97 | 0 | 0 | 18.85 | 4.51 | 8.61 | 1.43 | 0.00 | 0 | 832 | -4.37 |
| 2016 (5) | 122.01 | 4.68 | 22.01 | 1.38 | 10.36 | 14.48 | 0 | 0 | 18.04 | -3.16 | 8.49 | 9.35 | 0.00 | 0 | 870 | -3.76 |
| 2015 (4) | 116.55 | 8.3 | 21.71 | 11.33 | 9.05 | 1.46 | 0 | 0 | 18.63 | 2.8 | 7.76 | -6.32 | 0.00 | 0 | 904 | 22.33 |
| 2014 (3) | 107.62 | 2.38 | 19.5 | 9.43 | 8.92 | 10.12 | 0 | 0 | 18.12 | 6.89 | 8.29 | 7.57 | 0.00 | 0 | 739 | -7.04 |
| 2013 (2) | 105.12 | -1.68 | 17.82 | 2.83 | 8.1 | 10.81 | 0 | 0 | 16.95 | 4.59 | 7.71 | 12.7 | 0.00 | 0 | 795 | 0 |
| 2012 (1) | 106.92 | 0 | 17.33 | 0 | 7.31 | 0 | 0 | 0 | 16.21 | 0 | 6.84 | 0 | 0.00 | 0 | 0 | 0 |
